Literature DB >> 27673278

IL-36γ has proinflammatory effects on human endothelial cells.

Charlie Bridgewood1, Martin Stacey2, Adewonuola Alase3, Dimitris Lagos4, Anne Graham5, Miriam Wittmann1,3,6.   

Abstract

Interleukin-36 cytokines are predominantly expressed by epithelial cells. Significant upregulation of epidermal IL-36 is now a recognised characteristic of psoriatic skin inflammation. IL-36 is known to induce inflammatory responses in dendritic cells, fibroblasts and epithelial cells. Although vascular alterations are a hallmark of psoriatic lesions and dermal endothelial cells are well known to play a critical role in skin inflammation, the effects of IL-36 on endothelial cells are unexplored. We here show that endothelial cells including dermal microvascular cells express a functionally active IL-36 receptor. Adhesion molecules VCAM-1 and ICAM-1 are upregulated by IL-36γ stimulation, and this is reversed by the presence of the endogenous IL-36 receptor antagonist. IL-36γ-stimulated endothelial cells secrete the proinflammatory chemokines IL-8, CCL2 and CCL20. Chemotaxis assays showed increased migration of T-cells following IL-36γ stimulation of endothelial cells. These results suggest a role for IL-36γ in the dermal vascular compartment, and it is likely to enhance psoriatic skin inflammation by activating endothelial cells and promoting leucocyte recruitment.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-36; endothelial; inflammation; psoriasis; skin

Mesh:

Substances:

Year:  2017        PMID: 27673278     DOI: 10.1111/exd.13228

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  18 in total

Review 1.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

2.  Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Authors:  Aliyah M Weinstein; Nicolas A Giraldo; Florent Petitprez; Catherine Julie; Laetitia Lacroix; Frédérique Peschaud; Jean-François Emile; Laetitia Marisa; Wolf H Fridman; Walter J Storkus; Catherine Sautès-Fridman
Journal:  Cancer Immunol Immunother       Date:  2018-10-12       Impact factor: 6.968

3.  The mechanism on Prevotella melaninogenica promoting the inflammatory progression of oral lichen planus.

Authors:  Pan Xu; Ru-Ru Shao; Shi Zhang; Zheng-Wu Tan; Yi-Ting Guo; Yuan He
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

Review 4.  IL-36 in chronic inflammation and fibrosis - bridging the gap?

Authors:  Michael Elias; Shuai Zhao; Hongnga T Le; Jie Wang; Markus F Neurath; Clemens Neufert; Claudio Fiocchi; Florian Rieder
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 5.  IL-36 cytokines and gut immunity.

Authors:  Vu L Ngo; Michal Kuczma; Estera Maxim; Timothy L Denning
Journal:  Immunology       Date:  2021-02-24       Impact factor: 7.215

Review 6.  Endothelial Response to Glucocorticoids in Inflammatory Diseases.

Authors:  Karolina A Zielińska; Laura Van Moortel; Ghislain Opdenakker; Karolien De Bosscher; Philippe E Van den Steen
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

7.  IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.

Authors:  Wenming Wang; Xiaoling Yu; Chao Wu; Hongzhong Jin
Journal:  Int J Med Sci       Date:  2017-08-18       Impact factor: 3.738

8.  IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.

Authors:  Charlie Bridgewood; Gareth W Fearnley; Anna Berekmeri; Philip Laws; Tom Macleod; Sreenivasan Ponnambalam; Martin Stacey; Anne Graham; Miriam Wittmann
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

Review 9.  IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis.

Authors:  Erin Fahey; Sarah L Doyle
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

10.  IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.

Authors:  Laura Mercurio; Martina Morelli; Claudia Scarponi; Elan Z Eisenmesser; Nunzianna Doti; Gianluca Pagnanelli; Emanuela Gubinelli; Cinzia Mazzanti; Andrea Cavani; Menotti Ruvo; Charles A Dinarello; Cristina Albanesi; Stefania Madonna
Journal:  Cell Death Dis       Date:  2018-10-30       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.